Profectus receives grant to develop vaccine for Ebola and Marburg viruses

  Profectus BioSciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases, and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston announced May 2 they received a five-year $5.4 million grant from the National Institute of Allergy and Infectious...

David Block, CEO of Gliknik, to chair GBC Bioscience Committee

  The Greater Baltimore Committee announced June 5 David S. Block, MD, president and CEO of Gliknik, Inc. has been named chair of the Greater Baltimore Committee’s Bioscience Committee. Dr. Block was chosen because of his leadership in the greater Baltimore bioscience community and his history of successful bioscience entrepreneurship. “A key priority for this committee going forward will be supporting the creation and growth of innovative bioscience companies by … Continue reading

GBC supports bill improving upon Maryland Life Sciences Advisory Board

Last week, the GBC offered testimony supporting SB 405, a bill to add greater public-private sector balance to the Life Sciences Advisory Board by increasing its number of life science business members from four members to seven, and requiring at least four of those business members represent the small business community. Read the full testimony.

Donald Fry: Transportation legislation not the only issue on business radar in Annapolis

By Donald C. Fry While business advocates are focusing much attention on Governor Martin O’Malley’s proposal to address Maryland’s crisis in funding its transportation infrastructure, lawmakers are considering a number of other issues that would impact the state’s competitive business environment. Business and transportation advocates are reviewing the details of the governor’s bill filed last week that seeks to ultimately raise an estimated $613 million per year in new revenue … Continue reading

GBC supports revisions to the Stem Cell Research Act

The Greater Baltimore Committee last week offered testimony supporting a bill intended to more aggressively focus use of the state’s stem cell research funding on supporting commercialization of research. HB 289, sponsored by Delegate Brian Feldman (D-Montgomery), requires that at least one-third of grants be awarded to for-profit companies in the state. It also requires that, in selecting nonprofit grant recipients, priority be given to applicants that have co-development partnerships … Continue reading

2012 Bioscience Awards Applications Now Available

Applications for the FY2012 Biotechnology Development Awards for Biotechnology Commercialization or Translational Research now are available at These awards of up to $200,000 each are granted on a competitive basis by the state of Maryland through its Maryland Biotechnology Center. Applicants should choose to apply for one of the two programs depending upon the nature of the project for which they are seeking funding. The primary difference in the … Continue reading

Greater Baltimore Committee names four winners of 2011 Maryland Bioscience Awards

CEOs and companies from Maryland’s biotech community were honored today by the Greater Baltimore Committee as winners of the sixth annual Maryland Bioscience Awards.  The awards were presented during a breakfast ceremony at the University of Maryland, Baltimore BioPark.   Winners of the 2011 Bioscience Awards are: Best New Product or Progress: Steven J. Kubisen, Ph.D., President and CEO, Seguro Surgical, Inc., Columbia.  The core technology for Seguro Surgical’s first … Continue reading

Donald Fry: Tapping into Maryland’s potential for innovation

By Donald C. Fry Well over 200 entrepreneurs and business advocates descended on Annapolis earlier this week to urge state lawmakers to enact an O’Malley administration proposal that would create Invest Maryland – a premium tax credit program aimed at generating $100 million in private investment funding from insurance companies for early-stage bioscience and technology businesses in Maryland. Speaking to individual lawmakers and testifying to two key budget committees, advocates … Continue reading

Business advocates, entrepreneurs voice support for Invest Maryland to lawmakers

More than 200 entrepreneurs and bioscience, technology and business advocates descended on Annapolis on February 16 to urge state lawmakers to enact an administration bill that would create Invest Maryland – a premium tax credit program aimed at generating $100 million in private investment funding for emerging Maryland businesses. Under the proposals, tax credits would be issued to participating insurance companies that contribute capital to the fund for investments in … Continue reading

Tech advocates headed to Annapolis for Invest Maryland hearings

Small business owners, bioscience and technology industry entrepreneurs, and business advocates are expected to jam into hearing rooms in Annapolis on Wednesday as the General Assembly’s two key budget committees hear an administration bill to create Invest Maryland — premium tax credit program aimed at generating $100 million in private investment funding for emerging Maryland businesses. The bills, SB 180 and HB 173, will be heard at 1 p.m. before … Continue reading